Immunomonitoring of Breast Cancer Patients During Systemic Treatment

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 26, 2020

Primary Completion Date

May 26, 2030

Study Completion Date

May 26, 2030

Conditions
Breast Cancer
Interventions
OTHER

blood sample

"•Blood sample:~* 1 heparinized tube (4 mL) for collection of plasma and storage~* 1 heparinized tube (4 mL) for immunophenotyping,~* 4 EDTA tubes (4 x 10 mL) for collecting white blood cells (PBMC) for cryopreservation."

Trial Locations (2)

21079

RECRUITING

Centre Georges Francois Leclerc, Dijon

25000

NOT_YET_RECRUITING

CHRU Jean Minjoz, Besançon

All Listed Sponsors
lead

Centre Georges Francois Leclerc

OTHER

NCT04925856 - Immunomonitoring of Breast Cancer Patients During Systemic Treatment | Biotech Hunter | Biotech Hunter